Congratulations to Chuck Parker and John Phillips who co-authored a publication in the New England Journal of Medicine appearing June 2020. This publication describing the use of RNAi therapeutic Givosiran for Acute Intermittent Porphyria was selected by the editors of the NEJM as one of the notable articles published this past year.